These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7914468)

  • 1. Spontaneous functional recovery from parkinsonism is not due to reinnervation of the dorsal striatum by residual dopaminergic neurons.
    Rothblat DS; Schneider JS
    Brain Res Bull; 1994; 34(3):309-12. PubMed ID: 7914468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
    Rothblat DS; Schroeder JA; Schneider JS
    J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA; Rothblat DS; Joyce JN; Schneider JS
    Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: an in vivo electrochemical study.
    Rothblat DS; Schneider JS
    J Neurochem; 1999 Feb; 72(2):724-33. PubMed ID: 9930746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
    Schneider JS; Denaro FJ
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):452-8. PubMed ID: 2898510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
    Schneider JS; Yuwiler A; Markham CH
    Brain Res; 1987 May; 411(1):144-50. PubMed ID: 2886180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of striatal neurons to peripheral sensory stimulation in symptomatic MPTP-exposed cats.
    Schneider JS
    Brain Res; 1991 Mar; 544(2):297-302. PubMed ID: 2039944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats.
    Schneider JS; Rothblat DS
    Neuroscience; 1991; 44(2):421-9. PubMed ID: 1944893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.
    Pérez-Otaño I; Oset C; Luquin MR; Herrero MT; Obeso JA; Del Río J
    Neurosci Lett; 1994 Jul; 175(1-2):121-5. PubMed ID: 7970192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MPTP-induced ventral mesencephalic cell loss in the cat.
    Williams JL; Schneider JS
    Neurosci Lett; 1989 Jul; 101(3):258-62. PubMed ID: 2570385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular distribution of interleukin-1alpha-immunoreactivity after MPTP intoxication in mice.
    Hébert G; Mingam R; Arsaut J; Dantzer R; Demotes-Mainard J
    Brain Res Mol Brain Res; 2005 Aug; 138(2):156-63. PubMed ID: 15922486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated exposure to MPTP does not produce a permanent movement disorder in cats recovered from MPTP-induced parkinsonism.
    Rothblat DS; Schneider JS
    Neurodegeneration; 1995 Mar; 4(1):87-92. PubMed ID: 7600188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential recovery of sensorimotor function in GM1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: partial striatal dopaminergic reinnervation vs. neurochemical compensation.
    Schneider JS; Schroeder JA; Rothblat DS
    Brain Res; 1998 Nov; 813(1):82-7. PubMed ID: 9824674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in pallidal neuronal responses to peripheral sensory and striatal stimulation in symptomatic and recovered parkinsonian cats.
    Rothblat DS; Schneider JS
    Brain Res; 1995 Dec; 705(1-2):1-14. PubMed ID: 8821727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
    German DC; Dubach M; Askari S; Speciale SG; Bowden DM
    Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y; Watanabe A; Mori A; Koga N
    Biochem Biophys Res Commun; 1998 Jul; 248(3):660-3. PubMed ID: 9703982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism.
    Schneider JS; Yuwiler A
    Exp Neurol; 1989 Aug; 105(2):177-83. PubMed ID: 2568945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
    Zhang J; Graham DG; Montine TJ; Ho YS
    J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism.
    Schneider JS; Rothblat DS; DiStefano L
    Brain Res; 1994 Apr; 643(1-2):86-91. PubMed ID: 8032935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S; Fujitake J; Kuno S; Sano Y
    Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.